Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medtronic ( (MDT) ) has provided an update.
On May 18, 2026, Medtronic plc announced a leadership transition in its Neuroscience Portfolio, with Executive Vice President and President Brett Wall set to depart his role. Dr. Kweli Thompson, currently Senior Vice President and President of Cardiac Rhythm Management, will assume the position of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.
Mr. Wall will remain with Medtronic until September 1, 2026, to support an orderly handover of responsibilities within the neuroscience business. He will receive severance payments and benefits aligned with the company’s standard executive officer severance practices, underscoring a structured and planned transition for stakeholders in a key segment of Medtronic’s operations.
The most recent analyst rating on (MDT) stock is a Buy with a $110.00 price target. To see the full list of analyst forecasts on Medtronic stock, see the MDT Stock Forecast page.
Spark’s Take on MDT Stock
According to Spark, TipRanks’ AI Analyst, MDT is a Neutral.
MDT scores as above-average primarily due to solid financial performance anchored by strong free cash flow and a constructive earnings-call outlook with reiterated growth drivers. The score is held back by weak technicals (price in a downtrend with negative momentum), a relatively premium P/E despite a supportive dividend, and a post-call corporate event that reduced FY2026 EPS guidance due to MiniMed-related charges and dilution.
To see Spark’s full report on MDT stock, click here.
More about Medtronic
Medtronic plc is a global medical technology company that develops and manufactures devices and therapies across multiple healthcare portfolios, including neuroscience and cardiac rhythm management. The company focuses on advanced implantable devices and related technologies used in hospitals and clinical settings worldwide.
Average Trading Volume: 8,668,279
Technical Sentiment Signal: Sell
Current Market Cap: $97.77B
For a thorough assessment of MDT stock, go to TipRanks’ Stock Analysis page.